Next Article in Journal
Green Extraction of Annatto Seed Oily Extract and Its Use as a Pharmaceutical Material for the Production of Lipid Nanoparticles
Previous Article in Journal
Phytochemicals and Antioxidant Capacities of Young Citrus Fruits Cultivated in China
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Re-Analysis and Additional Information Needed to Inform Conclusions. Comment on Halenova et al. Deuterium-Depleted Water as Adjuvant Therapeutic Agent for Treatment of Diet-Induced Obesity in Rats. Molecules 2020, 25, 23

Department of Applied Health Science, Indiana University School of Public Health-Bloomington, Bloomington, IN 47405, USA
Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, IN 47405, USA
Authors to whom correspondence should be addressed.
Molecules 2022, 27(16), 5186;
Submission received: 3 March 2021 / Revised: 26 May 2022 / Accepted: 11 August 2022 / Published: 15 August 2022
We were interested to read the report by Halenova et al. [1], who tested the effect of deuterium-depleted water (DDW) on obesity-related outcomes using a rat model of diet-induced obesity (DIO) vs. control rats. Within each of these groups, the authors report randomizing half to DDW and the other half to MilliQ-filtered water for three weeks. The authors concluded that DDW mitigates DIO. We have concerns about how the data were analyzed based on treatment assignments, and question some of the reported results.
Regarding the statistical analyses, the authors report using Student’s t-test for their statistical comparisons, which has several potential concerns. First, whether animals were individual- or group-caged is not clear. The authors reference an unrelated prior study [2] for details of animals and housing in which they state that animals were housed in groups of five. The treatment in this study ([1]) was provided in water, which is reasonable to assume was provided to the cage, not each individual rat. If the same protocol was followed, then each condition (n = 10) was housed in two cages (n = 5 in each cage). The units of analysis are then not independent observations as assumed in a Student’s t-test. The correlation of animals within cage should be taken into consideration in the analysis, or the assessment of treatment effects may result in an inflated type I error rate [3,4,5,6]. If the animals were randomized by cage, this adds additional considerations as inferences are based on two units of assignment per group, not ten [7,8]. In addition to group-housing altering standard errors and degrees of freedom for any between-group tests, the cage-level treatment makes any food or water data represent averages across rats resulting from two independent measurements per treatment, not ten. Both scenarios (randomizing by cage and treating animals at the cage-level) need to be accounted for in power calculations to estimate sample size [6,7,9]; a sample size calculation was not reported by the authors. As in any power calculation, power is dependent on variability in the number of independent observations. By only having two independent observations for each condition (i.e., two cages for DDW and two for MilliQ-filtered water), this limits the degrees of freedom; there are only two independent groups per treatment. When considering group-housed animals, the estimate of the variability is dependent on the “design effect” (a function of the average number of rats per cage and intraclass correlation coefficient), details of which have been well documented elsewhere [4,7].
Second, additional information is needed to inform the conclusion about whether DDW has an anti-obesity effect. Per the authors’ Figure 1A, the percent weight gain relative to baseline weight at week 0 appears to be greater in the control (standard chow) + DDW group as compared to the control + MilliQ at week 8. In Figure 1B, however, body weight index (BWI; calculated as grams/cm2) in the control + DDW group is on average lower than both DIO groups. Plausible explanations for this include: (1) there were group imbalances at baseline so that the control rats had more growth potential, or (2) the animals had marked linear growth after the introduction of DDW so that BWI was lower than the other groups, despite the relatively higher change in weight. A more mundane explanation is that the treatments of animals or figures were misidentified. Because weight in neither grams nor lengths is reported, the reader is unable to determine which is more likely. Further, the authors report that the control + DDW group increased water intake compared to the control + MilliQ group, meaning that changes in weight are confounded by these differences.
Per their paper, the authors note “The experimental data used to support the findings of this study are available from the corresponding author upon request”. Unfortunately, we attempted to resolve our questions by contacting the authors for their data, but attempts by us and the journal to reach the authors were unsuccessful. We, therefore, request that the authors provide clarification to our inquiry, including clarifying whether rodents were group-treated and, if so, re-analyzing their results taking into consideration the hierarchical structure of the data, as well as reporting baseline body weights for each group. Per the data availability statement, we also request that raw data are shared so we and others may perform re-analyses. We furthermore request that the authors report p-values to exact values per reporting guidelines, instead of, e.g., “p < 0.05”, to aid interpretation [10].

Author Contributions

Conceptualization, A.W.B. and D.B.A.; discussion, all authors; original draft preparation, C.J.V.; writing—review and editing, all authors (C.J.V., X.C., D.E.C., L.M.M., S.L.D., D.B.A. and A.W.B.). All authors have read and agreed to the published version of the manuscript.


Supported in part by the Gordon and Betty Moore Foundation and NIH grants R25HL124208 and R25DK090880. The opinions expressed are those of the authors and do not necessarily represent those of the NIH or any other organization.

Conflicts of Interest

In the last thirty-six months, Dr. Brown has received travel expenses from University of Louisville; speaking fees from Kentuckiana Health Collaborative, Purdue University, and Rippe Lifestyle Institute, Inc.; consulting fees from Epigeum (Oxford University Press), LA NORC, and Pennington Biomedical Research Center. His wife is employed by Reckitt Benckiser. In the last thirty-six months, Dr. Allison has received personal payments or promises for same from: American Society for Nutrition; Alkermes, Inc.; American Statistical Association; Big Sky Health, Inc.; Biofortis; California Walnut Commission; Clark Hill PLC; Columbia University; Fish & Richardson, P.C.; Frontiers Publishing; Gelesis; Henry Stewart Talks; IKEA; Indiana University; Arnold Ventures (formerly the Laura and John Arnold Foundation); Johns Hopkins University; Kaleido Biosciences; Law Offices of Ronald Marron; MD Anderson Cancer Center; Medical College of Wisconsin; National Institutes of Health (NIH); Medpace; National Academies of Science; Sage Publishing; The Obesity Society; Sports Research Corp.; The Elements Agency, LLC; Tomasik, Kotin & Kasserman LLC; University of Alabama at Birmingham; University of Miami; Nestle; WW (formerly Weight Watchers International, LLC). Donations to a foundation have been made on his behalf by the Northarvest Bean Growers Association. Dr. Allison was previously an unpaid member of the International Life Sciences Institute North America Board of Trustees. The institution of the authors, Indiana University, and the Indiana University Foundation have received funds or donations to support their research or educational activities from: NIH; USDA; Indiana CTSI; Soleno Therapeutics; American Egg Board; California Walnut Commission, Almond Board; Peanut Institute; Mondelez; National Cattlemen’s Beef Association; Haas Avocado Board; Eli Lilly and Co.; Reckitt Benckiser Group PLC; Alliance for Potato Research and Education; American Federation for Aging Research; Dairy Management Inc.; Whistle Labs, Inc.; Arnold Ventures; the Gordon and Betty Moore Foundation; the Alfred P. Sloan Foundation; Center for Open Science; and numerous other for-profit and non-profit organizations to support the work of the School of Public Health and the university more broadly.


  1. Halenova, T.; Zlatskiy, I.; Syroeshkin, A.; Maximova, T.; Pleteneva, T. Deuterium-depleted water as adjuvant therapeutic agent for treatment of diet-induced obesity in rats. Molecules 2020, 25, 23. [Google Scholar] [CrossRef] [PubMed]
  2. Halenova, T.; Raksha, N.; Vovk, T.; Savchuk, O.; Ostapchenko, L.; Prylutskyy, Y.; Kyzyma, O.; Ritter, U.; Scharff, P. Effect of C 60 fullerene nanoparticles on the diet-induced obesity in rats. Int. J. Obes. 2018, 42, 1987–1998. [Google Scholar] [CrossRef]
  3. Sainani, K. The importance of accounting for correlated observations. PMR 2010, 2, 858–861. [Google Scholar] [CrossRef] [PubMed]
  4. Murray, D.M.; Varnell, S.P.; Blitstein, J.L. Design and analysis of group-randomized trials: A review of recent methodological developments. Am. J. Public Health 2004, 94, 423–432. [Google Scholar] [CrossRef] [PubMed]
  5. Lazic, S.E.; Clarke-Williams, C.J.; Munafò, M.R. What exactly is ‘N’in cell culture and animal experiments? PLoS Biol. 2018, 16, e2005282. [Google Scholar] [CrossRef] [PubMed]
  6. Basson, A.R.; LaSalla, A.; Lam, G.; Kulpins, D.; Moen, E.L.; Sundrud, M.S.; Miyoshi, J.; Ilic, S.; Theriault, B.R.; Cominelli, F. Artificial microbiome heterogeneity spurs six practical action themes and examples to increase study power-driven reproducibility. Sci. Rep. 2020, 10, 5039. [Google Scholar] [CrossRef] [PubMed]
  7. Brown, A.W.; Li, P.; Bohan Brown, M.M.; Kaiser, K.A.; Keith, S.W.; Oakes, J.M.; Allison, D.B. Best (but oft-forgotten) practices: Designing, analyzing, and reporting cluster randomized controlled trials. Am. J. Clin. Nutr. 2015, 102, 241–248. [Google Scholar] [CrossRef] [PubMed]
  8. Vorland, C.J.; Brown, A.W.; Dawson, J.A.; Dickinson, S.L.; Golzarri-Arroyo, L.; Hannon, B.A.; Heo, M.; Heymsfield, S.B.; Jayawardene, W.P.; Kahathuduwa, C.N. Errors in the implementation, analysis, and reporting of randomization within obesity and nutrition research: A guide to their avoidance. Int. J. Obes. 2021, 45, 2335–2346. [Google Scholar] [CrossRef] [PubMed]
  9. Chusyd, D.E.; Austad, S.N.; Brown, A.W.; Chen, X.; Dickinson, S.L.; Ejima, K.; Fluharty, D.; Golzarri-Arroyo, L.; Holden, R.; Jamshidi-Naeini, J. From Model Organisms to Humans, the Opportunity for More Rigor in Methodologic and Statistical Analysis, Design, and Interpretation of Aging and Senescence Research. J. Gerontol. Ser. A 2021, glab382. [Google Scholar] [CrossRef]
  10. Lang, T.A.; Altman, D.G. Basic statistical reporting for articles published in biomedical journals: The “Statistical Analyses and Methods in the Published Literature” or the SAMPL Guidelines. Int. J. Nurs. Stud. 2015, 52, 5–9. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Vorland, C.J.; Chen, X.; Chusyd, D.E.; Mestre, L.M.; Dickinson, S.L.; Allison, D.B.; Brown, A.W. Re-Analysis and Additional Information Needed to Inform Conclusions. Comment on Halenova et al. Deuterium-Depleted Water as Adjuvant Therapeutic Agent for Treatment of Diet-Induced Obesity in Rats. Molecules 2020, 25, 23. Molecules 2022, 27, 5186.

AMA Style

Vorland CJ, Chen X, Chusyd DE, Mestre LM, Dickinson SL, Allison DB, Brown AW. Re-Analysis and Additional Information Needed to Inform Conclusions. Comment on Halenova et al. Deuterium-Depleted Water as Adjuvant Therapeutic Agent for Treatment of Diet-Induced Obesity in Rats. Molecules 2020, 25, 23. Molecules. 2022; 27(16):5186.

Chicago/Turabian Style

Vorland, Colby J., Xiwei Chen, Daniella E. Chusyd, Luis M. Mestre, Stephanie L. Dickinson, David B. Allison, and Andrew W. Brown. 2022. "Re-Analysis and Additional Information Needed to Inform Conclusions. Comment on Halenova et al. Deuterium-Depleted Water as Adjuvant Therapeutic Agent for Treatment of Diet-Induced Obesity in Rats. Molecules 2020, 25, 23" Molecules 27, no. 16: 5186.

Article Metrics

Back to TopTop